UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 52

Sortiert nach

Progressive APOBEC3B mRNA expression in distant breast cancer metastases

PloS one, 2017-01, Vol.12 (1), p.e0171343

2017

Link zum Volltext

Verfügbarkeit prüfen

Prospects of Targeting the Gastrin Releasing Peptide Receptor and Somatostatin Receptor 2 for Nuclear Imaging and Therapy in Metastatic Breast Cancer

PloS one, 2017-01, Vol.12 (1), p.e0170536-e0170536

2017

Link zum Volltext

Verfügbarkeit prüfen

The circular RNome of primary breast cancer

Genome research, 2019-03, Vol.29 (3), p.356

2019

Link zum Volltext

Verfügbarkeit prüfen

Gene length corrected trimmed mean of M-values (GeTMM) processing of RNA-seq data performs similarly in intersample analyses while improving intrasample comparisons

BMC bioinformatics, 2018-06, Vol.19 (1), p.236-236, Article 236

2018

Link zum Volltext

Verfügbarkeit prüfen

CCAT2 , a novel long non-coding RNA in breast cancer: expression study and clinical correlations

Oncotarget, 2013-10, Vol.4 (10), p.1748-1762

2013

Link zum Volltext

Verfügbarkeit prüfen

MicroRNA-30c expression level is an independent predictor of clinical benefit of endocrine therapy in advanced estrogen receptor positive breast cancer

Breast cancer research and treatment, 2011-05, Vol.127 (1), p.43-51

2011

Link zum Volltext

Verfügbarkeit prüfen

Four miRNAs associated with aggressiveness of lymph node-negative, estrogen receptor-positive human breast cancer

Proceedings of the National Academy of Sciences - PNAS, 2008-09, Vol.105 (35), p.13021-13026

2008

Link zum Volltext

Verfügbarkeit prüfen

mRNA and microRNA Expression Profiles in Circulating Tumor Cells and Primary Tumors of Metastatic Breast Cancer Patients

Clinical cancer research, 2011-06, Vol.17 (11), p.3600-3618

2011

Link zum Volltext

Verfügbarkeit prüfen

Machine learning-based somatic variant calling in cell-free DNA of metastatic breast cancer patients using large NGS panels

Scientific reports, 2023-06, Vol.13 (1), p.10424-10424, Article 10424

2023

Link zum Volltext

Verfügbarkeit prüfen

PIK3CA mutations in ductal carcinoma in situ and adjacent invasive breast cancer

Endocrine-related cancer, 2019-05, Vol.26 (5), p.471-482

2019

Link zum Volltext

Verfügbarkeit prüfen

mRNA expression profiles in circulating tumor cells of metastatic colorectal cancer patients

Molecular oncology, 2015-04, Vol.9 (4), p.920-932

2015

Link zum Volltext

Verfügbarkeit prüfen

Tumor-agnostic ctDNA levels by mFAST-SeqS in first-line HR-positive, HER2 negative metastatic breast cancer patients as a biomarker for survival

NPJ breast cancer, 2023-07, Vol.9 (1), p.61-61, Article 61

2023

Link zum Volltext

Verfügbarkeit prüfen

APOBEC3B Gene Expression in Ductal Carcinoma In Situ and Synchronous Invasive Breast Cancer

Cancers, 2019-07, Vol.11 (8), p.1062

2019

Link zum Volltext

Verfügbarkeit prüfen

Circular RNA in Chemonaive Lymph Node Negative Colon Cancer Patients

Cancers, 2021-04, Vol.13 (8), p.1903

2021

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of the ability of adjuvant tamoxifen-benefit gene signatures to predict outcome of hormone-naive estrogen receptor-positive breast cancer patients treated with tamoxifen in the advanced setting

Molecular oncology, 2014-12, Vol.8 (8), p.1679-1689

2014

Link zum Volltext

Verfügbarkeit prüfen

Which Cyclin E Prevails as Prognostic Marker for Breast Cancer? Results from a Retrospective Study Involving 635 Lymph Node–Negative Breast Cancer Patients

Clinical cancer research, 2006-06, Vol.12 (11), p.3319-3328

2006

Link zum Volltext

Verfügbarkeit prüfen

Abstract P2-01-17: Circulating tumor cell count and levels of circulating tumor DNA are complementary prognostic biomarkers in metastatic breast cancer - A pilot study

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.P2-P2-01-17

2022

Link zum Volltext

Verfügbarkeit prüfen

mFAST-SeqS based aneuploidy score in circulating cell-free DNA and role as early response marker in patients with metastatic prostate cancer treated with androgen receptor signaling inhibitor

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.5058-5058

2023

Link zum Volltext

Verfügbarkeit prüfen

KRAS and BRAF mutation status in circulating colorectal tumor cells and their correlation with primary and metastatic tumor tissue

International journal of cancer, 2013-07, Vol.133 (1), p.130-141

2013

Link zum Volltext

Verfügbarkeit prüfen

Abstract 4978: On circular RNAs in breast cancer

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.4978-4978

2018

Link zum Volltext

Verfügbarkeit prüfen

T lymphocytes facilitate brain metastasis of breast cancer by inducing Guanylate-Binding Protein 1 expression

Acta neuropathologica, 2018-04, Vol.135 (4), p.581-599

2018

Link zum Volltext

Verfügbarkeit prüfen

A panel of DNA methylation markers for the classification of consensus molecular subtypes 2 and 3 in patients with colorectal cancer

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.3545-3545

2021

Link zum Volltext

Verfügbarkeit prüfen

Detection of Aneuploidy in Cerebrospinal Fluid from Patients with Breast Cancer Can Improve Diagnosis of Leptomeningeal Metastases

Clinical cancer research, 2021-05, Vol.27 (10), p.2798-2806

2021

Link zum Volltext

Verfügbarkeit prüfen

Genome‐wide aneuploidy detected by mFast‐SeqS in circulating cell‐free DNA is associated with poor response to pembrolizumab in patients with advanced urothelial cancer

Molecular oncology, 2022-05, Vol.16 (10), p.2086-2097

2022

Link zum Volltext

Verfügbarkeit prüfen

A panel of DNA methylation markers for the classification of consensus molecular subtypes 2 and 3 in patients with colorectal cancer

Molecular oncology, 2021-12, Vol.15 (12), p.3348-3362

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 52

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(46)
Mit Volltextzugriff
(50)

Publikationsform

Artikel
(52)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(34)
Life Sciences & Biomedicine
(29)
Humans
(27)
Oncology
(26)
Breast Cancer
(25)
Female
(22)
Tumors
(21)
Gene Expression
(17)
Breast Neoplasms - Genetics
(16)
Metastasis
(16)
Middle Aged
(14)
Breast Neoplasms - Pathology
(13)
Cancer
(12)
Metastases
(11)
Mutation
(11)
Prognosis
(11)
Aged
(10)
Genomics
(10)
Dna
(9)
Gene Expression Regulation, Neoplastic
(9)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Cancer Research
(7)
Molecular Oncology
(7)
Breast Cancer Research And Treatment
(5)
Oncotarget
(5)
Clinical Cancer Research
(3)
Journal Of Clinical Oncology
(3)
Cancers
(2)
Neuro-Oncology
(2)
Plos One
(2)
Scientific Reports
(2)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Progressive APOBEC3B mRNA expression in distant breast cancer metastases

Prospects of Targeting the Gastrin Releasing Peptide Receptor and Somatostatin Receptor 2 for Nuclear Imaging and Therapy in Metastatic Breast Cancer

The circular RNome of primary breast cancer

Gene length corrected trimmed mean of M-values (GeTMM) processing of RNA-seq data performs similarly in intersample analyses while improving intrasample comparisons

CCAT2 , a novel long non-coding RNA in breast cancer: expression study and clinical correlations

MicroRNA-30c expression level is an independent predictor of clinical benefit of endocrine therapy in advanced estrogen receptor positive breast cancer

Four miRNAs associated with aggressiveness of lymph node-negative, estrogen receptor-positive human breast cancer

mRNA and microRNA Expression Profiles in Circulating Tumor Cells and Primary Tumors of Metastatic Breast Cancer Patients

Machine learning-based somatic variant calling in cell-free DNA of metastatic breast cancer patients using large NGS panels

PIK3CA mutations in ductal carcinoma in situ and adjacent invasive breast cancer

mRNA expression profiles in circulating tumor cells of metastatic colorectal cancer patients

Tumor-agnostic ctDNA levels by mFAST-SeqS in first-line HR-positive, HER2 negative metastatic breast cancer patients as a biomarker for survival

APOBEC3B Gene Expression in Ductal Carcinoma In Situ and Synchronous Invasive Breast Cancer

Circular RNA in Chemonaive Lymph Node Negative Colon Cancer Patients

Evaluation of the ability of adjuvant tamoxifen-benefit gene signatures to predict outcome of hormone-naive estrogen receptor-positive breast cancer patients treated with tamoxifen in the advanced setting

Which Cyclin E Prevails as Prognostic Marker for Breast Cancer? Results from a Retrospective Study Involving 635 Lymph Node–Negative Breast Cancer Patients

Abstract P2-01-17: Circulating tumor cell count and levels of circulating tumor DNA are complementary prognostic biomarkers in metastatic breast cancer - A pilot study

mFAST-SeqS based aneuploidy score in circulating cell-free DNA and role as early response marker in patients with metastatic prostate cancer treated with androgen receptor signaling inhibitor

KRAS and BRAF mutation status in circulating colorectal tumor cells and their correlation with primary and metastatic tumor tissue

Abstract 4978: On circular RNAs in breast cancer

T lymphocytes facilitate brain metastasis of breast cancer by inducing Guanylate-Binding Protein 1 expression

A panel of DNA methylation markers for the classification of consensus molecular subtypes 2 and 3 in patients with colorectal cancer

Detection of Aneuploidy in Cerebrospinal Fluid from Patients with Breast Cancer Can Improve Diagnosis of Leptomeningeal Metastases

Genome‐wide aneuploidy detected by mFast‐SeqS in circulating cell‐free DNA is associated with poor response to pembrolizumab in patients with advanced urothelial cancer

A panel of DNA methylation markers for the classification of consensus molecular subtypes 2 and 3 in patients with colorectal cancer

Suchergebnisse filtern